LPL Financial’s GALENA BIOPHARMA INC COM RXII Stock Holding History

LPL Financial’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-11,674	Closed	-$4K	–	2862
2016 Q3	$4K	Sell	11,674 -4,506	-28%	-$1.54K	﹤0.01%	2628
2016 Q2	$10K	Sell	16,180 -16,180	-50%	-$10K	﹤0.01%	2604
2016 Q1	$54K	Buy	32,360 +16,000	+98%	+$26.7K	﹤0.01%	2998
2015 Q4	$23K	Buy	+16,360	New	+$23K	﹤0.01%	3101
2014 Q3	–	Sell	-50,631	Closed	-$155K	–	2857
2014 Q2	$155K	Buy	50,631 +1,425	+3%	+$4.36K	﹤0.01%	2547
2014 Q1	$123K	Buy	49,206 +33,700	+217%	+$84.2K	﹤0.01%	2536
2013 Q4	$77K	Sell	15,506 -11,000	-42%	-$54.6K	﹤0.01%	2579
2013 Q3	$56K	Buy	+26,506	New	+$56K	﹤0.01%	2487

LPL Financial's RXII Position: Q4 2016 in Review

LPL Financial sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 11,674 shares — an estimated $4K sold.

LPL Financial first reported a position in RXII in Q3 2013 and held it in 8 quarters. The position peaked at $155K in Q2 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

LPL Financial reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
LPL Financial sold 11,674 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $4K.
LPL Financial first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 8 quarters.
LPL Financial's GALENA BIOPHARMA INC COM position peaked at $155K in Q2 2014.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on LPL Financial's 13F filing for Q4 2016, filed 13 Feb 2017.